Comprehensive Cancer Center Leadership

Michael Kastan, MD, PhD
Director, Comprehensive Cancer Center
Department of Oncology

Mona J. Arreola, PhD
Associate Director, Administration

James Downing, MD
Co-Leader, Hematologic Malignancies Program
Associate Director, Basic Research
Department of Pathology

Michael A Dyer, PhD
Co-Leader, Developmental Therapeutics for Solid Malignancies Program
Department of Developmental Neurobiology

Amar Gajjar, MD
Co-Leader, Neurobiology and Brain Tumor Program
Department of Oncology

Richard J. Gilbertson, MD, PhD
Co-Leader, Neurobiology and Brain Tumor Program
Departments of Developmental Neurobiology and Oncology

Melissa Hudson, MD
Co-Leader, Cancer Prevention and Control Program
Department of Oncology

James N. Ihle, PhD
Co-Leader, Signal Transduction Program
Department of Biochemistry

Ching-Hon Pui, MD
Co-Leader, Hematologic Malignancies Program
Department of Oncology

Raul C. Ribeiro, MD
Associate Director, Outreach
Department of Oncology

Leslie L. Robison, PhD
Co-Leader, Cancer Prevention and Control Program
Department of Epidemiology and Cancer Control

Martine F. Roussel, PhD
Co-Leader, Signal Transduction Program
Department of Genetics and Tumor Cell Biology

Victor M. Santana, MD
Co-Leader, Developmental Therapeutics for Solid Malignancies Program
Associate Director, Clinical Research
Department of Oncology

Brenda Schulman, PhD
Co-Leader, Molecular Oncology Program
Departments of Genetics & Tumor Cell Biology and Structural Biology

Charles J. Sherr, MD, PhD
Co-Leader, Molecular Oncology Program
Department of Genetics & Tumor Cell Biology

Gerard P. Zambetti, PhD
Associate Director, Education and Training
Department of Biochemistry

Email This Article Email This Article   |   Print Print